Detalles de la búsqueda
1.
Prevalence of Systemic Hypertension and Control of Systolic Blood Pressure in a Cohort of 14 Dogs with Adrenal-Dependent Hypercortisolism during the First Year of Trilostane Treatment or after Adrenalectomy.
Animals (Basel)
; 14(3)2024 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38338154
2.
Survival of dogs with pituitary-dependent hyperadrenocorticism treated twice daily with low doses of trilostane.
Vet Rec
; 191(3): e1630, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35460587
3.
Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase-2 inhibitor and toceranib phosphate.
Vet Comp Oncol
; 20(1): 179-188, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34390295
4.
Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment.
J Vet Intern Med
; 35(1): 130-141, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33274787
5.
Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism.
J Vet Intern Med
; 34(5): 1768-1778, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32614466
6.
Laboratory assessment of trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism.
J Vet Intern Med
; 34(4): 1413-1422, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533623
Resultados
1 -
6
de 6
1
Próxima >
>>